(Q45077709)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Naoomi Tominaga

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Yasuto Naoi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Kazuki Kishi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Tomonori Tanei

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Yosuke Baba

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Seung Jin Kim

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Tetsuya Taguchi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Yasuhiro Tamaki

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Shinzaburo Noguchi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

English

0 references

publication date

29 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

633-641

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20803240%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-010-1145-z

13 February 2020

exact match

0 references

cites work

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Combining multiple microarray studies and modeling interstudy variation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Comparison of prognostic gene expression signatures for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Comparison of the predictive accuracy of DNA array-based multigene classifiers across cDNA arrays and Affymetrix GeneChips

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Clinical utility of the 70-gene MammaPrint profile in a Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Development of the 21-gene assay and its application in clinical practice and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Trial assessing individualized options for treatment for breast cancer: the TAILORx trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z

Gene-expression profiling in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1145-Z